Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)

NCT00179660

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Pacific Coast Hematology/Oncology Medical Group, Onc. Fountain Valley, California, United States
  • UC David Cancer Center Sacramento, California, United States
  • Sylvester Cancer CenterUniversity Of Miami Miami, Florida, United States
View Trial Details
Completed

Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area

NCT01426373

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Mark Rubin Beverly Hills, California, United States
  • Mitchel Goldman La Jolla, California, United States
  • Jeffrey Klein San Juan Capistrano, California, United States
  • Ava Shamban Santa Monica, California, United States
View all 18 locations
View Trial Details
Completed

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

NCT01459653

Conditions
Adnexal Diseases, Agranulocytosis, B-cell Lymphoma, +61 more
Locations
  • Sandoz Investigational Site Innsbruck, Austria
  • Sandoz Investigational Site Kufstein, Austria
  • Sandoz Investigational Site Leoben, Austria
  • Sandoz Investigational Site Deurne, Belgium
View all 117 locations
View Trial Details
Completed

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

NCT01748721

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +103 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • University of California San Francisco Medical Center - Parnassus San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 20 locations
View Trial Details
Completed

Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma

NCT00354926

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Alabama Medical Center Birmingham, Alabama, United States
  • UCLA Medical Hematology and Oncology Los Angeles, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details
Completed

A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer

NCT00141297

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Abramson Cancer Center Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Pharmacy/PCAM/West Pavillion Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions